SMTL ID : 3qkk.1

Spirochromane Akt Inhibitors

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

hetero-1-1-mer

Ligands

1 x SMH: N-(2-ethoxyethyl)-N-{(2S)-2-hydroxy-3-[(2R)-6-hydroxy-4-oxo-3,4-dihydro-1'H-spiro[chromene-2,3'-piperidin]-1'-yl]propyl}-2,6-dimethylbenzenesulfonamide(Non-covalent)

SMH.1: 25 residues within 4Å: Chain A: L.17, G.18, K.19, G.20, T.21, F.22, G.23, K.24, V.25, A.38, K.40, L.42, I.47, E.52, T.56, M.88, E.89, A.91, E.95, E.139, N.140, M.142, T.152, D.153, F.299 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:V.25, A:L.42, A:I.47, A:E.52 Hydrogen bonds: A:F.22, A:G.23, A:K.40, A:E.89, A:A.91 Water bridges: A:T.21, A:K.40, A:D.153 Salt bridges: A:D.153, A:D.153

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kallan, N.C. et al., Discovery and SAR of spirochromane Akt inhibitors. Bioorg.Med.Chem.Lett. (2011)

Release Date

2011-03-30

Peptides

RAC-alpha serine/threonine-protein kinase: A
Glycogen synthase kinase-3 beta: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
C

RAC-alpha serine/threonine-protein kinase

Glycogen synthase kinase-3 beta

Related Entries With Identical Sequence